The "other" signaling of trastuzumab: antibodies are immunocompetent drugs
- PMID: 18347004
- DOI: 10.1200/JCO.2007.15.7404
The "other" signaling of trastuzumab: antibodies are immunocompetent drugs
Comment on
-
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer.J Clin Oncol. 2008 Apr 10;26(11):1789-96. doi: 10.1200/JCO.2007.14.8957. Epub 2008 Mar 17. J Clin Oncol. 2008. PMID: 18347005
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
